Type 1 diabetes mellitus may have a higher risk for incident dementia when compared with type 2 diabetes mellitus.

Adults with diabetes had an elevated risk for dementia, with a higher risk among those with type 1 compared with type 2 ...

Patients with autoimmune thyroiditis who use semaglutide to manage their T2D have fewer TED-related diagnoses at 5 years.

Researchers have quantified the proportion of people with Type 2 diabetes who also have fatty pancreas disease. Read more.

Discover more about the anatomical sites at which people with Type 2 diabetes experience a particularly high risk of fracture.

Glenmark Pharmaceuticals has announced the launch of GLIPIQ (semaglutide) in India for the management of Type 2 Diabetes Mellitus (T2DM), positioning it as a more affordable GLP-1 therapy aimed at ...

The association between type 2 diabetes mellitus (T2DM) and spinal degenerative disorders (SDDs) may be method-dependent, according to a study published online July 3 in The Journal of Bone & Joint ...

Nearly 39 million American adults are currently living with diabetes, the latest data shows — and between 90% and 95% of those cases are type 2 diabetes. Type 1 diabetes, although it only makes up 5% ...

GLP-1 Drugs: New Reports of Dysesthesia and Allodynia A case series reports dysesthesia and allodynia in patients treated with semaglutide and tirzepatide, suggesting a possible dose related to ...

USV Private Limited, a leading name in diabetes care, has announced the launch of USEMA, its semaglutide injection, for the ...